News tagged ‘BasicResearch’ clear
- Lung cancer patients and their families often hope for more from treatment aimed at making them more comfortable, and oncologists may be failing to communicate to patients the limits of measures being offered, according to a study from Dr. Jane Weeks and Dr. Deborah Schrag.
Tags: BasicResearch, EndOfLife
- At the American Society of Hematology's annual meeting, Dr. Nikhil Munshi presented results from a study of the antibody BHQ880, which targets DKK-1, a protein that inhibits bone formation and is overabundant in people with multiple myeloma.
Tags: Antibody, BasicResearch, MultipleMyeloma
- At the AACR Annual Meeting 2013, George Demetri, MD, reported in a study that a simple blood sample revealed more cancer-causing mutations than a tumor biopsy alone.
- Dr. Bruce Spiegelman of Dana-Farber discussed his laboratory's discovery of a new type of energy-burning fat cell (called "beige fat") in adult humans, which he says may have therapeutic potential for treating obesity. Obesity is a risk factor for cancer.
- A study led by Dr. Jane Weeks suggests that many patients with advanced lung and colorectal cancer harbor the fundamental misperception that treatments that can extend life and alleviate pain might also cure them. Dr. Deborah Schrag, co-author of the study, said the researchers were also interested in examining whether where doctors worked might affect the way the message was communicated.
Tags: chemotherapy, BasicResearch, EndOfLife
- Researchers, including Dr. Matthew Meyerson and Dr. Bruce Johnson of Dana-Farber, found from a large study of the genetics of a common lung cancer, that more than half the tumors from that cancer have mutations that can be treated by drugs that are being developed or can be easily developed. (Full article requires a subscription)
Tags: BasicResearch, LungCancer, Genetics
- Glenn Dranoff, MD, was named to Stand Up to Cancer's latest research "dream team," which will focus on cancer immunology. Dana-Farber researchers will receive $1.5 million over three years to help support the study of tissue and blood samples from patients who are receiving specific experimental treatments.
Tags: BasicResearch, Grants
- Dana-Farber has been named one of six research centers that will share a $16 million grant from the Edward P. Evans Foundation to study Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood.
- Dr. George Demetri comments on a new blood test that reveals more of the gene mutations that sustain certain digestive-tract tumors than a DNA analysis of a traditional tumor biopsy.